The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global microfluidics market size reached US$ 20.9 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 52.4 Billion by 2027, exhibiting a CAGR of 16.47% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Microfluidics is a technology that relies on a set of tools or systems to manipulate small volumes of fluids and control chemical, biological, and physical processes relevant to sensing. It can be integrated with electronic and optical elements for the construction of operational sensors using lithographic techniques. It is widely utilized in biomedical applications, such as tissue engineering and wound healing, to control living systems. Nowadays, advanced fabrication technologies like two-photon polymerization (2PP) are used to fabricate miniature microfluidic components, such as microneedles, microfilters, micromixers, micropumps, microvalves, and photonic sensors. These components offer unique three-dimensional (3D) capabilities, extreme resolution, and sufficient versatility.
The increasing number of new infections and deaths due to coronavirus disease (COVID-19) is driving the demand for microfluidics-based detection approaches that can help develop rapid, effective, and easy-to-use clinical detection techniques. Besides this, lab-on-chip (LOC) devices, which are microsystems capable of integrating biological or chemical laboratories in a single chip, are finding wide applications in scientific research. This represents another major factor catalyzing the demand for miniature microfluidic components on account of their improved compactness and functionalities. Moreover, microfluidics has distinct advantages, including high sensitivity, specificity, controlled fluid handling, low volume sampling, low-cost prototyping, and rapid readout. This, in confluence with the growing prevalence of acute and chronic diseases across the globe, is positively influencing the adoption of microfluidics for blood analysis and point of care (POC) testing of cancer and infectious diseases. In addition, the rising popularity of nanofibers in tissue engineering and regenerative medicine is contributing to market growth. Furthermore, as microfluidics enables the custom-made fabrication of nanofibers in a broad range of materials and morphologies, their sales are increasing around the world.
IMARC Group provides an analysis of the key trends in each sub-segment of the global microfluidics market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on material, component and application.
Breakup by Material:
Breakup by Component:
Breakup by Application:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Agilent Technologies Inc., Bio-Rad Laboratories Inc., Blacktrace Holdings Ltd, Elvesys Group, Fluidigm Corporation, Illumina Inc., Micronit B.V., Parker-Hannifin Corporation, PerkinElmer Inc., Qiagen N.V. and Thermo Fisher Scientific Inc.
|Base Year of the Analysis||2021|
|Segment Coverage||Material, Component, Application, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Abbott Laboratories, Agilent Technologies Inc., Bio-Rad Laboratories Inc., Blacktrace Holdings Ltd, Elvesys Group, Fluidigm Corporation, Illumina Inc., Micronit B.V., Parker-Hannifin Corporation, PerkinElmer Inc., Qiagen N.V. and Thermo Fisher Scientific Inc.|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at